Aqr Arbitrage LLC Ibere Pharmaceuticals Transaction History

Aqr Arbitrage LLC

$1.9 Billion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$0.11 - $9.94 $11,705 - $1.06 Million	106,415 Added 106.42%	206,415 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$9.77 - $9.84 $977,000 - $984,000	100,000 New	100,000 $981,000
Q4 2021 Feb 14, 2022	SELL	$9.68 - $9.77 $744,392 - $751,313	-76,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.61 - $9.78 $18,259 - $18,582	1,900 Added 2.53%	76,900 $745,000
Q2 2021 Aug 16, 2021	BUY	$9.65 - $9.95 $723,750 - $746,250	75,000 New	75,000 $725,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Arbitrage LLC with notifications on news.